139 related articles for article (PubMed ID: 1100970)
21. Chemotherapeutic trials in leprosy. 5. A study of methods used in clinical trials in lepromatous leprosy.
Waters MF; Rees RJ; Sutherland I
Int J Lepr Other Mycobact Dis; 1967; 35(3):311-35. PubMed ID: 4917107
[No Abstract] [Full Text] [Related]
22. [Resistance of Mycobacterium leprae to sulfones (DDS) and rifampicin in recurring lepromatous leprosy in Martinique and Guadeloupe since February 1980].
Guelpa-Lauras CC; Constant-Desportes M; Millan J; Grosset J
Acta Leprol; 1982; (86-87):77-80. PubMed ID: 6816000
[No Abstract] [Full Text] [Related]
23. Dapsone Resistance in Leprosy Patients Originally from American Samoa, United States, 2010-2012.
Williams DL; Araujo S; Stryjewska BM; Scollard D
Emerg Infect Dis; 2018 Aug; 24(8):1584-1585. PubMed ID: 30016255
[TBL] [Abstract][Full Text] [Related]
24. [New WHO recommendations for the treatment of leprosy].
Acta Leprol; 1997; 10(4):189. PubMed ID: 9527754
[No Abstract] [Full Text] [Related]
25. Secondary dapsone-resistant leprosy in Shanghai Municipality.
Ji BH; Chen JK; Zhang JL; Hou YH; Ni GX; Zhang RB
Lepr Rev; 1983 Sep; 54(3):197-202. PubMed ID: 6355724
[No Abstract] [Full Text] [Related]
26. Rifampicin for lepromatous leprosy: nine years' experience.
Waters MF; Rees RJ; Pearson JM; Laing AB; Helmy HS; Gelber RH
Br Med J; 1978 Jan; 1(6106):133-6. PubMed ID: 339995
[TBL] [Abstract][Full Text] [Related]
27. Sulphone resistance in leprosy. A review of one hundred proven clinical cases.
Pearson JM; Rees RJ; Waters MF
Lancet; 1975 Jul; 2(7924):69-72. PubMed ID: 49662
[TBL] [Abstract][Full Text] [Related]
28. Characteristics of the multiplication of dapsone-resistant strains of Mycobacterium leprae in mice. Subcommittee on Clinical Trials of the C hemotherapy of Leprosy (THELEP) Scientific Working Group of UNDP/World Bank/WHO Special Programme for Research and Training in Tropical Diseases.
Lepr Rev; 1988 Mar; 59(1):5-10. PubMed ID: 3294541
[No Abstract] [Full Text] [Related]
29. Nongranulomatous involvement of the bone marrow in lepromatous leprosy.
Suster S; Cabello-Inchausti B; Robinson MJ
Am J Clin Pathol; 1989 Dec; 92(6):797-801. PubMed ID: 2686398
[TBL] [Abstract][Full Text] [Related]
30. Reply: recommending drug regimens to smear negative MB cases after prolonged dapsone monotherapy.
Noordeen SK
Lepr Rev; 1991 Sep; 62(3):340. PubMed ID: 1795596
[No Abstract] [Full Text] [Related]
31. How much non-infectious are the "non-infectious" lepromatous leprosy patients?
Prabhakar MC; Appa Rao AV; Krishna DR; Ramanakar TV
Lepr India; 1983 Jul; 55(3):576-83. PubMed ID: 6361383
[TBL] [Abstract][Full Text] [Related]
32. Do leprosy patients in Papua New Guinea take their dapsone?
Ree GH; Taylor VE
P N G Med J; 1979; 22(2):145-7. PubMed ID: 399578
[No Abstract] [Full Text] [Related]
33. Ultrastructural alterations of mycobacterium leprae in skin biopsies of untreated and treated lepromatous patients.
Silva MT; Macedo PM; Costa MH; Gonçalves H; Torgal J; David HL
Ann Microbiol (Paris); 1982; 133(1):75-92. PubMed ID: 7051933
[TBL] [Abstract][Full Text] [Related]
34. Management of sulphone-resistant lepromatous leprosy.
Jopling WH
Lepr Rev; 1977 Jun; 48(2):127-8. PubMed ID: 330998
[No Abstract] [Full Text] [Related]
35. Multicentre controlled comparative trial of clofazimine and dapsone in low dosages.
Ahrens TF; Pettit JH; Ridley DS; Glaus L
Lepr Rev; 1975 Dec; 46(4):287-96. PubMed ID: 1107728
[No Abstract] [Full Text] [Related]
36. The response to chemotherapy of serum Mycobacterium leprae-specific antigen in multibacillary leprosy patients.
Roche PW; Britton WJ; Neupane KD; Failbus SS; Cho SN; Theuvenet WJ
Am J Trop Med Hyg; 1991 Jun; 44(6):702-8. PubMed ID: 1858971
[TBL] [Abstract][Full Text] [Related]
37. Chemotherapy trial with a triple-drug regimen, including once-monthly Rimactane (Rifampicin), in patients with multibacillary types of leprosy.
Reyes-Javier PD; Tantiongco PR
Acta Leprol; 1983; 1(3):133-41. PubMed ID: 6359801
[No Abstract] [Full Text] [Related]
38. Experimental and clinical studies on rifampicin in treatment of leprosy.
Rees RJ; Pearson JM; Waters MF
Br Med J; 1970 Jan; 1(5688):89-92. PubMed ID: 4903972
[TBL] [Abstract][Full Text] [Related]
39. Susceptibility of strains of Mycobacterium leprae isolated prior to 1977 from patients with previously untreated lepromatous leprosy.
Shepard CC; Rees RJ; Levy L; Pattyn SR; Baohong J; Dela Cruz EC
Int J Lepr Other Mycobact Dis; 1986 Mar; 54(1):11-5. PubMed ID: 3519796
[TBL] [Abstract][Full Text] [Related]
40. Primary dapsone-resistant leprosy in Cebu, Philippines.
Guinto RS; Cellona RV; Fajardo TT; de la Cruz EC
Int J Lepr Other Mycobact Dis; 1981 Dec; 49(4):427-30. PubMed ID: 7042607
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
